Opioids in patients with COPD and refractory dyspnea: literature review and design of a multicenter double blind study of low dosed morphine and fentanyl (MoreFoRCOPD)

Opioids in patients with COPD and refractory dyspnea: literature review and design of a multicenter double blind study of low dosed morphine and fentanyl (MoreFoRCOPD)

Abstract Background Refractory dyspnea or breathlessness is a common symptom in patients with advanced chronic obstructive pulmonary disease (COPD), with a high negative impact on quality of life (QoL). Low dosed opioids have been investigated for refractory dyspnea in COPD and other life-limiting c...

Full description

Bibliographic Details
Main Authors: Marlies van Dijk, Kris J. M. Mooren, Jan-Willem K. van den Berg, Wendy J. C. van Beurden-Moeskops, Roxane Heller-Baan, Sander M. de Hosson, Wai Yee Lam-Wong, Liesbeth Peters, Karin Pool, Huib A. M. Kerstjens
Format: Article
Language:English
Published: BMC 2021-09-01
Series:BMC Pulmonary Medicine
Subjects:
COPD
Refractory dyspnea
Breathlessness
Opioids
Online Access:https://doi.org/10.1186/s12890-021-01647-8

Internet

https://doi.org/10.1186/s12890-021-01647-8

Similar Items